Proteomics International Laboratories Ltd (PIQ:ASX)

76.0¢

right-arrow Created with Sketch. 0.015 (2.01%)
MCAP $79.72M
Last trade 15.04pm 22/01/2021 20mins delayed

Latest Announcements

22/12/2020PIQProteomics International Laboratories Ltd
26/11/2020PIQProteomics International Laboratories Ltd
26/11/2020 Price SensitivePSPIQProteomics International Laboratories Ltd
12/11/2020 Price SensitivePSPIQProteomics International Laboratories Ltd
05/11/2020 Price SensitivePSPIQProteomics International Laboratories Ltd
03/11/2020PIQProteomics International Laboratories Ltd
03/11/2020PIQProteomics International Laboratories Ltd
03/11/2020 Price SensitivePSPIQProteomics International Laboratories Ltd

Company Overview

Proteomics International Laboratories Limited is a biological research and drug discovery company. The Company operates in three business units unified by a technology platform: Analytical services, which includes specialist contract research, analytical testing and consultancy; Diagnostics, which includes biomarkers of disease and personalized medicine, and Therapeutics, which includes peptide drug discovery from venoms. The Company focuses on the PromarkerD, a proteomics-derived predictive and diagnostic test for diabetic kidney disease. The Company focuses on its diagnostics portfolio using the Promarker platform, and is investigating proteins associated with endometriosis, mesothelioma and other conditions. The Company has a therapeutic drug discovery program targeting new analgesic (painkilling) and antibiotic drug compounds. The Company also has a laboratory to analyze the make-up of biosimilar drugs as being like-for-like with the brand name drugs they seek to replace.

PIQ in the news

Search Previous Announcements